Latest Trends in Companies & Industries
Top hashtags
Top influencers
BiotechWorld 
biospace 
PharmaScrip 
pharmaphorum 
matthewherper 
FiercePharma 
NatureBiotech 
ReutersScience 
SanofiUS 
eduardoarmienta Top sources
Monthly report: January 2020
This month, The Essentials Report, has curated & analyzed the content published by 114 influencers like Biotech World and BioSpace, discussing hashtags such as #biotech , #coronavirus and #biospace.
Read our monthly report or learn more about Essentials.
What matters to our readers VS what matters to the rest of the world in January 2020
Popular with our readers
Best articles in January 2020
China Coronavirus Update: An Interview with Infectious Disease Specialist Sean Beckmann
The spreading of the coronavirus that began in Wuhan, China has researchers and health officials worldwide studying the emerging virus and preparing to treat it and develop vaccines. ...
China Coronavirus Update: An Interview with Infectious Disease Specialist Sean Beckmann
The spreading of the coronavirus that began in Wuhan, China has researchers and health officials worldwide studying the emerging virus and preparing to treat it and develop vaccines. ...
Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany
The US company bluebird bio has launched the first gene therapy for the blood disorder transfusion-dependent beta thalassemia in the EU, with a hospital in Germany becoming its first qualified treatment center. ...
Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany
The US company bluebird bio has launched the first gene therapy for the blood disorder transfusion-dependent beta thalassemia in the EU, with a hospital in Germany becoming its first ...
As Chinese Coronavirus Spreads, Biopharma and Governments Rush to Develop Vaccines
China’s National Health Commission stated today that the coronavirus has infected 5,974 individuals, resulting in 132 deaths and 103 people being cured.
As Chinese Coronavirus Spreads, Biopharma and Governments Rush to Develop Vaccines
China’s National Health Commission stated today that the coronavirus has infected 5,974 individuals, resulting in 132 deaths and 103 people being cured.
Big pharma joins hunt for coronavirus vaccine as outbreak escalates
Big pharma has joined the hunt for a vaccine for the deadly coronavirus outbreak that is beginning to spread around the world from its origins in China.
Big pharma joins hunt for coronavirus vaccine as outbreak escalates
Big pharma has joined the hunt for a vaccine for the deadly coronavirus outbreak that is beginning to spread around the world from its origins in China.
Budget 2020 | Cheer for science as key departments get a raise
Key departments get 13% more than what was spent last year; biotechnology gets largest hike
Budget 2020 | Cheer for science as key departments get a raise
Key departments get 13% more than what was spent last year; biotechnology gets largest hike
BioNTech Expands Cancer Portfolio With US Biotech Acquisition
German cancer specialist BioNTech will acquire US T-cell therapy biotech Neon Therapeutics in a deal worth €60M, both to expand its cancer therapy pipeline and establish a US base. ...
BioNTech Expands Cancer Portfolio With US Biotech Acquisition
German cancer specialist BioNTech will acquire US T-cell therapy biotech Neon Therapeutics in a deal worth €60M, both to expand its cancer therapy pipeline and establish a US base. ...
GSK hands TB vaccine to Gates Foundation's nonprofit biotech
GlaxoSmithKline has licensed a tuberculosis vaccine to the Bill & Melinda Gates Medical Research Institute. The deal sets the stage for a push to build on recent phase 2b data and make the vaccine available in low-income countries where TB is prevalent.
GSK hands TB vaccine to Gates Foundation's nonprofit biotech
GlaxoSmithKline has licensed a tuberculosis vaccine to the Bill & Melinda Gates Medical Research Institute. The deal sets the stage for a push to build on recent phase 2b data and make the ...
Roche's digital partnerships flourish under live-and-let-live approach
Roche has a long history of being relatively hands off with the companies it buys; just look at Genentech, its U.S. subsidiary, for proof. And that way of doing business has served it well, particularly when it comes to growing its digital partnerships.
Roche's digital partnerships flourish under live-and-let-live approach
Roche has a long history of being relatively hands off with the companies it buys; just look at Genentech, its U.S. subsidiary, for proof. And that way of doing business has served it well, ...
